Fontana, Pierre

 
 
Show items per page
Elements: 109
Page 2 on 3

2014

Scientific Articles

add to browser selection
Analysis of 339 pregnancies in 181 women with 13 different forms of inherited thrombocytopeniaNoris, Patrizia; Lecompte, Thomas Pierre; Boehlen, Françoise; Fontana, Pierre;
add to browser selection
Antiplatelet Therapy: Targeting the TxA2 PathwayFontana, Pierre; Zufferey Bakos, Anne; Daali, Youssef; Reny, Jean-Luc;
add to browser selection
Characterization of the platelet granule proteome: Evidence of the presence of MHC1 in alpha-granulesZufferey Bakos, Anne; Schvartz, Domitille; Nolli, Severine; Reny, Jean-Luc; ... Fontana, Pierre
add to browser selection
Direct oral anticoagulants in the treatment and long-term prevention of venous thrombo-embolismFontana, Pierre; Goldhaber, Samuel Z; Bounameaux, Henri;
add to browser selection
Evaluation of the GEM®PCL Plus point-of-care device for neonatal coagulation assessment: An observational study on cord bloodDe Luca, Roberta; Fontana, Pierre; Poncet, Antoine; De Moerloose, Philippe; Pfister, Riccardo
add to browser selection
Fibrinogen geneva II: a new congenitally abnormal fibrinogen alpha chain (Gly17Asp) with a review of similar mutations resulting in abnormal knob A.Casini, Alessandro; De Maistre, Emmanuel; Casini-Stuppi, Virginie; Fontana, Pierre; ... De Moerloose, Philippe
add to browser selection
Hémostase. Aspirine: une ou deux fois par jour?Fontana, Pierre; Casini, Alessandro; Boehlen, Françoise; Reny, Jean-Luc;
add to browser selection
How to manage prasugrel and ticagrelor in daily practiceBonhomme, Fanny; Fontana, Pierre; Reny, Jean-Luc;
add to browser selection
Impact of high glucose concentration on aspirin-induced acetylation of human serum albumin: An in vitro studyFinamore, Francesco; Priego-Capote, Feliciano; Gluck, Florent; Zufferey, Anne; ... Sanchez, Jean-Charles
add to browser selection
Refinement of the cutoff values of the HemosIL AcuStar assay for the detection of anticardiolipin and anti-beta2 glycoprotein-1 antibodiesFontana, Pierre; Poncet, Antoine; Lindhoff-Last, E; De Moerloose, Philippe; Devreese, K M
add to browser selection
Role of paraoxonase-1 in CYP2C19 loss-of-function carriersDaali, Youssef; Reny, Jean-Luc; Fontana, Pierre;
add to browser selection
Sputtered titanium oxynitride coatings for endosseous applications: Physical and chemical evaluation and first bioactivity assaysBanakh, Oksana; Moussa, Mira; Matthey, Joël; Pontearso, Alessandro; ... Durual, Stéphane

2013

Scientific Articles

add to browser selection
Antiplaquettaires et patients âgés : quelles molécules et quelles preuves ?Reny, Jean-Luc; Roffi, Marco; Fontana, Pierre;
add to browser selection
Gestes invasifs et patients sous anticoagulants oraux : to bridge or not to bridge ?Kopp, Garance; Fontana, Pierre; Grosgurin, Olivier;
add to browser selection
Gestion péri-interventionnelle des nouveaux agents antiplaquettairesSchnyder-Joris, Coralie; Bonhomme, Fanny; Bonvini, Robert; Fontana, Pierre;
add to browser selection
Hémostase : nouveaux anticoagulants oraux : de la théorie à la pratiqueDe Moerloose, Philippe; Casini, Alessandro; Boehlen, Françoise; Fontana, Pierre;
add to browser selection
Management of major bleeding complications and emergency surgery in patients on long-term treatment with direct oral anticoagulants, thrombin or factor-Xa inhibitors: Proposals of the Working Group on Perioperative Haemostasis (GIHP) - March 2013Pernod, Gilles; Albaladejo, Pierre; Godier, Anne; Samama, Charles M; ... Sié, Pierre
add to browser selection
Tailored Thienopyridine therapy: no urgency for CYP2C19 genotypingFontana, Pierre; Cattaneo, Marco; Combescure, Christophe; Reny, Jean-Luc;
add to browser selection
The Human Diabetes Proteome Project (HDPP): From network biology to targets for therapies and preventionTopf, Florian; Schvartz, Domitille; Gaudet, Pascale; Priego-Capote, F.; ... Sanchez, Jean-Charles
add to browser selection
Thrombotic complications of myeloproliferative neoplasms: risk assessment and risk-guided managementCasini, Alessandro; Fontana, Pierre; Lecompte, Thomas Pierre;
add to browser selection
Unraveling modulators of platelet reactivity incardiovascular patients using omics strategies: Towards anetwork biology paradigmZufferey Bakos, Anne; Ibberson, Mark; Reny, Jean-Luc; Xenarios, Ioannis; ... Fontana, Pierre

2012

Scientific Articles

add to browser selection
Antiplatelet drug response status does not predict recurrent ischemic events in stable cardiovascular patients: results of the Antiplatelet Drug Resistances and Ischemic Events studyReny, Jean-Luc; Berdagué, Philippe; Poncet, Antoine; Barazer, Isabelle; ... Fontana, Pierre
add to browser selection
Aspirin for venous thromboembolism prevention and treatment: a renewal?Bounameaux, Henri; Fontana, Pierre;
add to browser selection
Influence of the paraoxonase-1 Q192R genetic variant on clopidogrel responsiveness and recurrent cardiovascular events: a systematic review and meta-analysisReny, Jean-Luc; Combescure, Christophe; Daali, Youssef; Fontana, Pierre;
add to browser selection
Platelet proteomicsZufferey Bakos, Anne; Fontana, Pierre; Reny, Jean-Luc; Nolli, Severine; Sanchez, Jean-Charles
add to browser selection
Poor responsiveness to antiplatelet drugs in acute coronary syndromes: clinical relevance and managementReny, Jean-Luc; Bonvini, Robert; Bonvini, John M; Roffi, Marco; Fontana, Pierre
add to browser selection
Prevalence of poor biological response to clopidogrel: a systematic reviewMallouk, Nora; Labruyère, Carine; Reny, Jean-Luc; Chapelle, Céline; ... Laporte, Silvy
add to browser selection
The paraoxonase-1 pathway is not a major bioactivation pathway of clopidogrel in vitroAncrenaz, Virginie; Desmeules, Jules Alexandre; James, Richard William; Fontana, Pierre; ... Daali, Youssef

Thesis supervisions

add to browser selection
A network-based approach to elucidate determinants of platelet reactivity in aspirin-treated cardiovascular patientsZufferey Bakos, Anne;
| 1 | 2 | 3 |